All News

2017

November

Media Release / Nov 14, 2017

New data reinforces clinical basis for switching to Sandoz biosimilar medicines

Read More

October

Media Release / Oct 27, 2017

Sandoz proposed biosimilar pegfilgrastim accepted by EMA for regulatory review

Read More
Media Release / Oct 24, 2017

Novartis delivered growth on top and bottom line in all divisions in Q3

Read More

September

Media Release / Sep 14, 2017

Sandoz proposed biosimilar adalimumab matches reference biologic in terms of efficacy and safety in long-term study

Read More
Media Release / Sep 12, 2017

Sandoz proposed biosimilar rituximab accepted for review by the FDA

Read More

August

Media Release / Aug 29, 2017

Sandoz invests in major expansion of global headquarters in Holzkirchen, Germany

Read More
Media Release / Aug 29, 2017

Lancet Haematology publishes data demonstrating Sandoz Rixathon® (biosimilar rituximab) matches efficacy and safety of reference biologic

Read More

July

Media Release / Jul 25, 2017

Sandoz expands partnership with World Child Cancer, to help children access treatment in four developing countries

Read More
Media Release / Jul 18, 2017

Q2 results confirm full year guidance. Strong pipeline results underpin potential of several highly innovative products

Read More

June

Media Release / Jun 27, 2017

Sandoz receives approval in Europe for Erelzi® (biosimilar etanercept) to treat multiple inflammatory diseases

Read More

Pages